Cargando…

Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease

OBJECTIVE: The aim of this in vitro study was to formulate an in situ thermoreversible injectable gel with poloxamer (PM) and methylcellulose (MC) to deliver simvastatin (SMV) in a controlled manner. SUBJECTS AND METHODS: Preformulation studies (Fourier transform infrared and differential scanning c...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajendran, Swaminathan, Kumar, K. Sathesh, Ramesh, S., Rao, Suresh Ranga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553261/
https://www.ncbi.nlm.nih.gov/pubmed/28929053
http://dx.doi.org/10.4103/jphi.JPHI_26_17
_version_ 1783256601500581888
author Rajendran, Swaminathan
Kumar, K. Sathesh
Ramesh, S.
Rao, Suresh Ranga
author_facet Rajendran, Swaminathan
Kumar, K. Sathesh
Ramesh, S.
Rao, Suresh Ranga
author_sort Rajendran, Swaminathan
collection PubMed
description OBJECTIVE: The aim of this in vitro study was to formulate an in situ thermoreversible injectable gel with poloxamer (PM) and methylcellulose (MC) to deliver simvastatin (SMV) in a controlled manner. SUBJECTS AND METHODS: Preformulation studies (Fourier transform infrared and differential scanning calorimetry) to assess the interaction between SMV and MC and PM were performed before gel formulation. Keeping the concentration of SMV at 2.2%, the concentration of PM and MC was altered to formulate in situ thermosensitive gel at 37°C. Rheological studies were carried to analyze the physical property of the various formulations. Drug release profile and stability studies were done for the selected formulation. The in vitro drug release profile was carried out for using open end tube method and ultraviolet spectroscopy. RESULTS: The preformulation studies showed that there is no interaction between the polymer and drug based on the rheological studies of different formulation, the formulation. F8 gels at 37°C and attains a viscosity of 4150 cps. CONCLUSIONS: PM 25% and MC 5% formed an ideal thermosensitive injectable gel at 37°C for subgingival delivery of SMV and also show controlled drug release for the period of 10 days in vitro.
format Online
Article
Text
id pubmed-5553261
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-55532612017-09-19 Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease Rajendran, Swaminathan Kumar, K. Sathesh Ramesh, S. Rao, Suresh Ranga Int J Pharm Investig Original Research Article OBJECTIVE: The aim of this in vitro study was to formulate an in situ thermoreversible injectable gel with poloxamer (PM) and methylcellulose (MC) to deliver simvastatin (SMV) in a controlled manner. SUBJECTS AND METHODS: Preformulation studies (Fourier transform infrared and differential scanning calorimetry) to assess the interaction between SMV and MC and PM were performed before gel formulation. Keeping the concentration of SMV at 2.2%, the concentration of PM and MC was altered to formulate in situ thermosensitive gel at 37°C. Rheological studies were carried to analyze the physical property of the various formulations. Drug release profile and stability studies were done for the selected formulation. The in vitro drug release profile was carried out for using open end tube method and ultraviolet spectroscopy. RESULTS: The preformulation studies showed that there is no interaction between the polymer and drug based on the rheological studies of different formulation, the formulation. F8 gels at 37°C and attains a viscosity of 4150 cps. CONCLUSIONS: PM 25% and MC 5% formed an ideal thermosensitive injectable gel at 37°C for subgingival delivery of SMV and also show controlled drug release for the period of 10 days in vitro. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5553261/ /pubmed/28929053 http://dx.doi.org/10.4103/jphi.JPHI_26_17 Text en Copyright: © 2017 International Journal of Pharmaceutical Investigation http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Research Article
Rajendran, Swaminathan
Kumar, K. Sathesh
Ramesh, S.
Rao, Suresh Ranga
Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease
title Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease
title_full Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease
title_fullStr Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease
title_full_unstemmed Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease
title_short Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease
title_sort thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553261/
https://www.ncbi.nlm.nih.gov/pubmed/28929053
http://dx.doi.org/10.4103/jphi.JPHI_26_17
work_keys_str_mv AT rajendranswaminathan thermoreversibleinsitugelforsubgingivaldeliveryofsimvastatinfortreatmentofperiodontaldisease
AT kumarksathesh thermoreversibleinsitugelforsubgingivaldeliveryofsimvastatinfortreatmentofperiodontaldisease
AT rameshs thermoreversibleinsitugelforsubgingivaldeliveryofsimvastatinfortreatmentofperiodontaldisease
AT raosureshranga thermoreversibleinsitugelforsubgingivaldeliveryofsimvastatinfortreatmentofperiodontaldisease